Defense News April 9, 2021
According to a new report from the Council on Strategic Risks, the U.S. Defense Department should dramatically increase funding for biological defense initiatives to at least $2 billion in the next year followed by increasing it to a range of $6.5 billion to $7 billion annually in the coming years. It will deter other nations from seeking to exploit America’s perceived vulnerability to a medical crisis. Key investment areas should include nucleic-acid based therapeutics, field-and-clinic deployable early-detection technology that can identify any pathogen by reading its genetic material and expanding international cooperation on biodefense issues and launching annual drills for rapid-response capabilities…read more.